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ABSTRACT 
A 3 years old child with a history of ingestion of Paracetamol tablet due to fever Presented 
with rashes all over the body, nikolsky sign positive  diagnosed as toxic epidermal necrosis, 
was treated With supportive management antibiotics and dexamethasone nursed on banana 
leaves which were autoclaved, the child improved within 10 days. 
Keywords: Paracetamol, Nikolsky sign, Toxic epidermal necrosis.
1. INTRODUCTION : 
Stevens-Johnson syndrome and Toxic 
Epidermal Necrolysis are the most concerning 
drug reactions affecting adults and children 
[1]. They are rare but severe reactions that 
predominantly involve the skin and mucous 
membranes and are considered medical 
emergencies as they are potentially fatal. 
Drugs are identified as the main cause of 
SJS/TEN causing 77-95% of cases commonly 
implicated drugs being antimicrobials, anti-
epileptic drugs and non-steroidal anti-
inflammatory agents (NSAIDs). Mycoplasma 
pneumoniae and Herpes simplex virus 
infections are  other well documented causes 
[2], [3]. Their overall annual incidence has 
been reported in 1–10 cases/ 1 million, of 
which 20% are paediatric cases. Mortality 
rates in SJS range between 1% and 4%, 
whereas in TEN it increases to between 25% 
and 35%, being somewhat lower in children 
[1]. The treatment of SJS/TEN includes 
supportive care, monitoring of fluids and 
electrolytes, barrier nursing care, and control 
of infection. The use of steroids and other 
immunosuppressive therapy still remains 
controversial [4]. 
2. CASE REPORT  
A 3 years old child came with H/O 
consumption of paracetamol tablets for fever 
as per the dosage, following which the child 
developed rashes, maculopapular, with itching, 
rashes turned more severe with bullous 
exfoliation of epidermis and extensive 
necrosis. On examination 85 % of Surface of 
the body was full of bullae, extensive 
defoliation and necrosis. Nikolosky sign  on 
initial assessment, HR – 120 bpm, RR – 
50cycles/minute BP – 70/40mm Hg Weight -
12kgs, height -90 cms, HC – 49cmsS/E was 
normal. The investigations revealed 
neutrophilic leucocytosis, normal electrolyte 
and creatinine levels. 1ST day of hospitalization  
child needed fluid resuscitation fluid after 
adequate fluid replacement, BP also got 
stabilised, Treatment pattern was 
multidirectional involving, Replacement of 
fluids, maintenance of electrolyte imbalance 
,Antibiotic therapy (inj  Augmentin 
80mg/kg/day in divided doses), Inj 
metronidazole 6mg/kg/dose TID, Inj amikacin  
20mg/kg/day single dose OD .On 
dermatological consultation, Inj 
dexamethasone  4mg IV BD X7days Silverex  
Ointment L/A  BD. Child was nursed in 
banana leaves  which was presterilized, child 
improved within 10 days and was discharged, 
no sequelae on follow up. 
3. DISCUSSION  
Cutaneous adverse drug reactions can be 
caused by a wide variety of drugs. The 
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incidence of adverse drug reactions in 
hospitalized children is 9.5% [4]. TEN and 
SJS are considered to be two ends of a 
spectrum of severe epidermolytic adverse 
cutaneous drug reactions, differing only by 
their extent of skin detachment. These are 
characterized by mucocutaneous tenderness 
and hemorrhagic erosions, erythema and 
epidermal detachment presenting as blisters 
and areas of denuded skin [2]. Stevens–
Johnson syndrome/toxic epidermal necrolysis 
in children does not differ significantly from 
adult SJS/TEN. Although drugs are the most 
common culprits in both children and adults, 
the likelihood of infections like 
Mycoplasma and Cytomegalovirus inducing 
SJS/TEN is relatively higher in children as 
compared to adults. Sulphonamides, 
penicillins and nonsteroidal anti-inflammatory 
drugs anticonvulsants are more commonly 
implicated in drug-induced pediatric 
SJS/TEN. Stevens–Johnson syndrome and 
toxic epidermal necrolysis rarely cause 
mortality in children, but significant morbidity 
is seen [5]. 
The management includes withdrawal of the 
offending drug, prompt institution of 
supportive therapy, preventing infection and 
management of complications [5]. 
Corticosteroids, intravenous immunoglobulin 
and cyclosporine have been utilized for 
specific therapy of pediatric SJS/TEN in 
various studies [6 - 8]. SJS/TEN is a life 
threatening condition and therefore supportive 
care is an essential part of management. A 
major part of supportive care consists of the 
management of fluid and electrolyte 
requirements. Intravenous fluid is given to 
maintain urine output. Wounds are treated 
without skin debridement as blistered skin acts 
as a natural biological dressing which helps in 
re-epithelialization [2],[9]. Dressing of the 
denuded area is done with paraffin or 
petrolatum gauze, with or without antibiotic 
impregnation. Adhesive dressings and topical 
sulfa containing medications are to be avoided. 
Frequent changes in patient position and water 
bed are ecommended which helps in quick 
recovery [5]. In this child, as the child did not 
have any reaction to syrup paracetamol, the 
reaction which happened to the child could be 
due to the content “sunset yellow” in 
paracetamol tablet. Due to the financial 
constraints of the patient we nursed the patient 
with autoclaved banana leaves. The patient 
responded very well without any sequelae. 
4. CONCLUSION 
Toxic Epidermal necrosis in children is often 
fatal when large surface of skin  is affected, in 
this child nursing on banana leaves, the drug 
trigger being paracetamol tablet, the complete 
recovery of the child are the unusual features 
to be noted in this child. 
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